Investor insights
Sectors invested in
Biotechnology1
Health Care1
Medical1
Funding rounds participated in
$53M sweet spot round size
Most of their 1 investments are in rounds between $53M and $53M
Investor type
Venture Capital
Basic info
Industry
venture capital and private equity principals
Sectors
Biotechnology
Therapeutics
Venture Capital
Date founded
2015
Investments made
A
Antiva Biosciences, Inc. / previously know as Hera Therapeutics raised $53M on April 27, 2023
Investors: GV, Canaan, Lumira Ventures, Adjuvant Capital, Sofinnova Ventures, Russia technology fund and BioImpact Capital